Insider Stock Trader

Insider buy OBIO

Orchestra BioMed Holdings, Inc. director Eric S Fain picks up 20,000 shares worth $100,000

The director paid an average of $5.00 a share, according to a Form 4 filed with the SEC on Nov 9.

Eric S Fain purchased about $100,000 of Orchestra BioMed Holdings, Inc. (OBIO) stock on Nov 9, according to an SEC filing. The director paid an average of $5.00 for 20,000 shares.

The purchase was made in the open market, not through an award, an option exercise or a plan. Other Orchestra BioMed Holdings, Inc. insiders have also bought: Four insiders made open-market purchases within 14 days, a pattern known as a cluster buy.

It is the sixth insider purchase at Orchestra BioMed Holdings, Inc. reported in the last 90 days. The purchase raises the insider's holding by 20%, to 119,630 shares.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The purchase
CompanyOrchestra BioMed Holdings, Inc. (OBIO)
InsiderEric S Fain
RoleDirector
TransactionOpen-market purchase (code P)
Shares20,000
Average price$5.00
Value$100,000
Trade dateNov 9, 2026
Filed with the SECNov 9, 2026, 4:32 PM ET
Shares held after119,630
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

See more details on this insider purchase

View the Form 4 on SEC.gov

Read the daily insider trading roundup · See where several insiders traded together

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.